K Number
K070280
Date Cleared
2007-02-23

(25 days)

Product Code
Regulation Number
870.1425
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

CardioDay® is a Holter software which is indicated for patients who may benefit from a long-term continuous electrocardiographic (ECG) recording, including, but not limited to, those with complaints of palpitations, syncope, chest pain, shortness of breath, or those that need to be monitored to judge their current cardiac functionality such as patients who have recently received pacemakers.

Device Description

CardioDay® does not perform any diagnosis of data by itself but only displays ECG morphologies and associated, claudited graphs such as heart rate trends, RR variability, and other statistical values in graphical form. The physician will be able to review, edit, and print the data collected.

AI/ML Overview

The provided document describes a Special 510(k) notification for the CardioDay® software, which is a Holter ECG device. The submission focuses on demonstrating substantial equivalence to a legally marketed predicate device (CardioDay® Version 1.9.5, K051471) rather than presenting a performance study with specific acceptance criteria that would typically involve numerical metrics like sensitivity, specificity, or accuracy for an AI/algorithm-driven device.

The "acceptance criteria" in this context are primarily related to the functional equivalence of the new version (CardioDay® Version 2.0) to the predicate device and compliance with relevant medical device standards. The study proving this effectively involves comparing the technical and functional characteristics of the new device to the predicate.

Here's an analysis based on the provided text, addressing your specific points:

1. A table of acceptance criteria and the reported device performance

Since this is a Special 510(k) for a software update rather than a new device with novel AI algorithms, the "acceptance criteria" are not reported as specific performance metrics (e.g., sensitivity, specificity) but rather as functional and technical equivalence to the predicate device and compliance with standards. The "reported device performance" is the demonstration that these equivalences and compliances are met.

Below is a summary table based on the document's comparison of the new device (CardioDay® Version 2.0) to the legally marketed predicate (CardioDay® Version 1.9.5). The acceptance criterion implicitly embedded in this type of submission is "maintains all predicate functionalities" and "introduces no new safety or effectiveness concerns."

Acceptance Criteria (Functional Equivalence / Compliance)Reported Device Performance (CardioDay® Version 2.0 vs. Predicate)
Hardware Specifications: CPU, RAM, Hard Disk Space, Display, Peripherals (CD-ROM, Operating System, Ports, Printer, Keyboard, Mouse, Installation Media, Further Periphery)All specifications are either identical or improved (e.g., increased minimum RAM, updated OS compatibility), maintaining or exceeding predicate capabilities. New features like Bluetooth connectivity are noted.
Software Features (Patient Screen): Patient ID, Name, Address, Personal Data, Medication, Indication, Physician's Name, Date of RecordingAll features are identical ("Yes" for both new and predicate).
Software Features (Analysis Options): Analysis Duration, Primary Channel Selection, Sensitivity/Signal Quality, Tachycardia/Bradycardia Threshold, Pause Duration, Prematurity, R on T, Pacemaker Type/Thresholds, Superimposition/QuickScan, 12-Lead ECG Module, Holter Data TransferAll features are identical ("Yes" for both new and predicate).
Software Features (Events Detected): VES/PVC, SVES/SVE, Couplet, Triplet, VTACH, Bigeminy, R on T, ST-Analysis, SVTACH, Arrhythmia, Bradycardia, Burst, V. STIM, A. STIM, AV. STIM, Undersense, Exitblock, Oversense, Pause, Event Marker, HR Stripes, Artifact, NormalAll event detection capabilities are identical ("Yes" for both new and predicate).
Software Features (Functionality Available): Start, Read Tape/Digital Recorder, Import, Analyze New, Open, Edit Patient Data, Print Preview, Print, Close Recording/Close, Delete Recording, Archive, Diagnosis, View ECG (Online via OptoLink/USB/Bluetooth), Screen Calibration/Setup, FFT Setup, Report Setup, Various Displays (Classes, PM Events, Events, HR Min./Max., Statistics, Diagnosis, Overview), Help FunctionsMost functionalities are identical. New features include "View ECG Online via USB Cable" and "View ECG Online via Bluetooth Data Transfer" (not present in predicate).
Software Features (Icons/Buttons Available): Start: Read Digital/Tape Recorder, Open Existing Record, Digital Recorder, Tape Recorder, Open: List of Patients, Print, Rhythm Analysis, Print PreviewAll features are identical ("Yes" for both new and predicate). The document notes "The label and form of the icons/buttons, however, are different."
Software Features (Options Available): Classes, Events, Heart Rate Min/Max, Average Heart Rate, Statistics (FFT, ST Diagrams), Report, Overview, Heart Rate Variability (RR Delay, RR FFT, 24h RR FFT, RR Histograms)All features are identical ("Yes" for both new and predicate). The document notes "The name of those options may vary."
Software Features (Graphics & Displays Available): Basis Sampling Rate for Graphical Displays, Classified Beats, Zoomed/Context of Selected Beat, Events, Heart Rate Trend, Average RR Interval, Y-T, RR > 50ms Distribution, FFT/ST Diagrams, Overview 2 channels.The "Basis Sampling Rate for Graphical Displays" was improved from 8 ms to 4 ms. A new indicator for Atrial Fibrillation was added. All other features are identical.
Software Features (Printout Options): Full Disclosure (various channels/times), Marked Events (various per page/channels), Event Table/Histogram, HR/ST Diagrams, HR diagram + Min/Max, RR Intervals/Delay/Histograms/Spectra, Pacemaker Event Histogram/Function Analysis, Report, Print to File (PDF), Save as Default OptionAll features are identical ("Yes" for both new and predicate). The document notes "The commands to generate a given printout as well as its appearance do vary."
Software Features (Editing & Reviewing Options): Scroll through Beats/Events, Edit Beat Labels/Event Marker, View Patient Event Markers, Jump from Statistics/Overview to ECG, Select Time Interval for RR Parameters, Edit ReportAll features are identical ("Yes" for both new and predicate). The document notes "The label and appearance of those options may vary."
Supported Recorders: RZ153+ Digital Recorder, CardioMem® CM 3000, CardioMem® CM 3000-12, CardioMem® CM 3000-12BTRZ153+, CM 3000, CM 3000-12 are supported in both. CM 3000-12BT is newly supported with Bluetooth functionality.
Compliance with Standards: 21 CFR 820, ISO 9001:2000 / ISO 13485:2003, IEC 60601-1-4, ANSI/AAMI EC38, IEC 60601-2-47, ISO 14971, EN 980, EN 1041, ISO 15223The new device continues to comply with all listed standards, as well as several FDA guidelines ("Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" and "General Principles of Software Validation").

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document explicitly states: "Clinical testing was not required to demonstrate substantial equivalence of safety and effectiveness." This implies there was no formal "test set" of patient data used in the sense of a clinical trial or performance evaluation for the software's diagnostic capabilities. The evaluation was primarily based on a comparison of technical and functional specifications and compliance with standards. Therefore, information on sample size, data provenance, retrospective/prospective nature is not applicable or not provided in this submission.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Since clinical testing was not performed and no patient data test set was used for diagnostic performance evaluation, there were no experts used to establish ground truth for a test set. The submission focuses on software verification and validation, ensuring that the software functions as intended and is equivalent to the predicate device.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

As no clinical test set was utilized for evaluating diagnostic performance, no adjudication method was applied to a test set.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

No MRMC comparative effectiveness study was done. The CardioDay® software, as described, "does not perform any diagnosis of data by itself but only displays ECG morphologies and associated, claudited graphs such as heart rate trends, RR variability, and other statistical values in graphical form. The physician will be able to review, edit, and print the data collected." It is a tool for physicians to review and analyze Holter ECG data, not an AI diagnostic algorithm that assists human readers in making a diagnosis from scratch.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

The software is explicitly stated to be a tool for physicians and "does not perform any diagnosis of data by itself." Therefore, a standalone performance evaluation (algorithm only) designed to establish diagnostic accuracy was not performed nor would it be appropriate for a device with this stated functionality. Its performance is tied to its role as a display and analysis tool for human interpretation.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

Given that no clinical performance study was conducted, there was no ground truth established for diagnostic accuracy. The "ground truth" for this submission revolves around the software's functional correctness and compliance with its own specifications and relevant standards.

8. The sample size for the training set

The document does not describe any machine learning or AI models requiring a "training set." Therefore, information on the sample size for a training set is not applicable or not provided.

9. How the ground truth for the training set was established

As there is no mention of a training set for machine learning/AI, this point is not applicable. The "ground truth" for the software's development likely refers to software requirements specifications, design documents, and medical device standards against which its functionality was verified.

{0}------------------------------------------------

Special 510(k) Notificationgetemec
CardioDay®Project ID: 0505S1
Executive - SummarySection 16-0001-Rev B
  • 510(k) Summary
Name and address of themanufacturer and sponsorof the 510(k) submission:getemed Medizin- und Informationstechnik AGOderstr. 7714513 TeltowGermanyTel.: +49 3328 - 3942-0Fax: +49 3328 – 3942-99
Official contact personfor all correspondence:Dr. Bert SchadowRegulatory Affairs ManagerE-mail: schadow@getemed.de
Manufacturing Facility:getemed Medizin- und Informationstechnik AGOderstr. 7714513 TeltowGermany
Date of Preparation:2006-12-19
Device Name / Trade Name:CardioDay®
Generic name of the device:Holter ECG
Classification of new device:Class II
Classification Panel:Computer, Diagnostic, Programmable
Product Code and:DQK
CFR Regulation Number:21 CFR 870.1425
Legally Marketed Devices:CardioDay® (K051471, getemed AG)

Description of Device:

CardioDay® does not perform any diagnosis of data by itself but only displays ECG morphologies and associated, claudited graphs such as heart rate trends, RR variability, and other statistical values in graphical form. The physician will be able to review, edit, and print the data collected.

SpecificationsLegally marketed device CardioDay Version 1.9.5 (K051471)New / Modified Device CardioDay Version 2.0
TypeIBM PC AT compatibleIBM PC AT compatible
CPUPentium III, 500MHz or greaterPentium III, 500MHz or greater
RAM128 Mbytes minimum,256 Mbytes minimum for XP256 Mbytes minimum
Free hard disk space5 GB minimum20 GB for 12-lead recordings5 GB minimum20 GB for 12-lead recordings
Display17" CRT or 15" TFT, 1024 x 768pixel (XGA), 256 colors17" CRT or 15" TFT, 1024 x 768pixel (XGA), 256 colors
Disc drive / floppy driveNot requiredNot required

Comparison of Device Technological Characteristics to Predicate Device:

0505S1-Sec16-0001-RevB-CardioDay-510k_Summary.doc CONFIDENTIAL AND PROPRIETARY

{1}------------------------------------------------

Special 510(k) Notificationgetemed
CardioDay®Project ID: 0505S1
Executive - SummarySection 16-0001-Rev B
SpecificationsLegally marketed deviceCardioDay Version 1.9.5 (K051471)New / Modified DeviceCardioDay® Version 2.0
CD-ROM driveFor installation only.Needs to be replaced by a CD-ROM writer or DVD writer if archiveoption implementedFor installation only.Needs to be replaced by a CD-ROM writer or DVD writer if archiveoption implemented
Operating systemWindows 98 SE, NT (SP6a),2000 or XPWindows 2000 or XP (SP2)
Ports1 parallel port sufficient; if USBdevices used for printing, softwarekey or card reader, thencorresponding USB ports required1 parallel port sufficient; if USBdevices used for printing, softwarekey, card reader, Bluetooth-Dongle,or connection for Holter recorderCardioMem® then correspondingUSB ports required
PrinterPrinter as any Windows™compatible, 300 dpiPrinter as any Windows™compatible, 300 dpi
KeyboardStandard deviceStandard device
MouseStandard, 2 or 3-button deviceStandard, 2 or 3-button device
Installation media(1) CD(1) CD
Further peripheryCompactFlash (Type I) memorycard readerCompactFlash (Type I) memorycard reader

Comparison of Software Characteristics:

Patient ScreenLegally marketed device CardioDay Version 1.9.5 (K051471)New / Modified Device CardioDay Version 2.0
Patient Identification NumberYesYes
Patient Name, Address, TelephoneYesYes
Patient Personal Data (Age, Gender, Date of Birth,etc.)YesYes
MedicationYesYes
IndicationYesYes
Physician's NameYesYes
Date of RecordingYesYes
Analysis OptionsLegally marketed deviceCardioDay® Version 1.9.5(K051471)New / Modified DeviceCardioDay® Version 2.0
Analysis DurationYesYes
Primary Channel SelectionYesYes
Sensitivity / Signal QualityYesYes
Tachycardia Threshold [bpm]YesYes
Bradycardia Threshold [bpm]YesYes
Pause Duration [ms]YesYes
SV Prematurity [%]YesYes
V Prematurity [%]YesYes
R on T [ms]YesYes
Pacemaker TypeYesYes
Minimum Pulse Rate [bpm]YesYes
Maximum Pulse Rate [bpm]YesYes

0505S1-Sec16-0001-RevB-CardioDay-510k_Summary.doc
CONFIDENTIAL AND PROPRIETARY

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------· 4/5

{2}------------------------------------------------

Special 510(k) NotificationCardioDay®getemedProject ID: 0505S1
Executive - SummarySection 16-0001-Rev B
Analysis OptionsLegally marketed deviceCardioDay® Version 1.9.5(K051471)New / Modified DeviceCardioDay® Version 2.0
Superimposition / QuickScanYesYes
12-Lead ECG ModuleYesYes
Holter Data TransferYesYes
Events DetectedLegally marketed deviceCardioDay Version 1.9.5(K051471)New / Modified DeviceCardioDay Version 2.0
VES / PVCYesYes
SVES / SVEYesYes
CoupletYesYes
TripletYesYes
VTACH / VE TachycardiaYesYes
BigeminyYesYes
R on TYesYes
ST-AnalysisYesYes
SVTACH / SVE TachycardiaYesYes
Arrhythmia / N-N DelayYesYes
BradycardiaYesYes
Burst / VE Run (4 beats)YesYes
V. STIM / V. PacedYesYes
A. STIM / A. PacedYesYes
AV. STIM / AV PacedYesYes
Undersense / Sense FailureYesYes
Exitblock / Capture FailureYesYes
Oversense / InhibitionYesYes
Pause / R-R Pause / N-N PauseYesYes
Event MarkerYesYes
HR StripesYesYes
ArtifactYesYes
NormalYesYes
Functionality AvailableLegally marketed deviceCardioDay® Version 1.9.5(K051471)New / Modified DeviceCardioDay® Version 2.0
The comparison between the legally marketed device and the NEW DEVICE is based on their functions only and not on their names.
StartYesYes
Read TapeYesYes
Read Digital RecorderYesYes
ImportYesYes
Analyze NewYesYes
OpenYesYes
Edit Patient DataYesYes
Print PreviewYesYes
PrintYesYes
Close RecordingYesYes
CloseYesYes

0505S1-Sec16-0001-RevB-CardioDay-510k_Summary.doc
CONF!DENTIAL AND PROPRIETARY

公司 >

..

រ ។

: 上

{3}------------------------------------------------

Special 510(k) Notificationgetemed
CardioDay®Project ID: 0505S1
Executive - SummarySection 16-0001-Rev B
Functionality AvailableLegally marketed deviceCardioDay Version 1.9.5(K051471)New / Modified DeviceCardioDay Version 2.0
Delete RecordingYesYes
ArchiveYesYes
DiagnosisYesYes
View ECGYesYes
View ECG Online via OptoLink CableYesYes
View ECG Online via USB CableNoYes
View ECG Online via Bluetooth Data TransferNoYes
Print PreviewYesYes
Screen Scale CalibrationYesYes
Screen: Color SetupYesYes
FFT SetupYesYes
Report SetupYesYes
Classes DisplayYesYes
PM Events DisplayYesYes
Events DisplayYesYes
HR Min./Max. DisplayYesYes
Statistics DisplayYesYes
Diagnosis DisplayYesYes
Overview DisplayYesYes
Context sensitive HelpYesYes
Keyboard Shortcuts HelpYesYes
Menu Entries HelpYesYes
Help: AboutYesYes
Help: VersionYesYes
Icons/Buttons AvailableLegally marketed deviceCardioDay® Version 1.9.5(K051471)New / Modified DeviceCardioDay® Version 2.0
The following comparison between the legallymarketed device and the NEW DEVICE is based ontheir functions only. The label and form of the icons/ buttons, however, are different. It might even takemore than one click to initiate a given action.
Start: Read Digital RecorderYesYes
Start: Read Tape RecorderYesYes
Start: Open Existing RecordYesYes
Digital RecorderYesYes
Tape RecorderYesYes
Open: List of PatientsYesYes
PrintYesYes
Rhythm AnalysisYesYes
Print Preview on ScreenYesYes

1 6

114/14

1 - 1

{4}------------------------------------------------

Special 510(k) Notificationgetemed
CardioDay®Project ID: 0505S1
Executive - SummarySection 16-0001-Rev B
Options AvailableLegally marketed deviceCardioDay® Version 1.9.5(K051471)New / Modified DeviceCardioDay® Version 2.0
The following comparison between the legally mar-keted device and the NEW DEVICE is based on theirfunctions only. The name of those options may vary.
ClassesYesYes
EventsYesYes
Heart Rate Min/MaxYesYes
Average Heart RateYesYes
Statistics: FFT AnalysisYesYes
Statistics: ST DiagramsYesYes
ReportYesYes
OverviewYesYes
Heart Variability: RR DelayYesYes
Heart Rate Variability: RR FFTYesYes
Heart Rate Variability: 24h RR FFTYesYes
Heart Rate Variability: RR HistogramsYesYes
Graphics & Displays AvailableLegally marketed deviceCardioDay Version 1.9.5(K051471)New / Modified DeviceCardioDay Version 2.0
The following comparison between the legally mar-keted device and the NEW DEVICE is based on theirfunctions only. The label and appearance of thosedisplays may vary.
Basis Sampling Rate for Graphical Displays8 ms4 ms
Classified Beats Grouped into Morphology BinsYesYes
Zoomed Version of Selected BeatYesYes
Context of Selected BeatYesYes
EventsYesYes
Heart Rate Trend in Recording PeriodYesYes
Average RR IntervalYesYes
Y-T DistributionYesYes
RR > 50ms DistributionYesYes
FFT AnalysisYesYes
ST DiagramsYesYes
Overview 2 channels at Different Scaling FactorsYesYes
Indicator for Atrial FibrillationNoYes
Printout OptionsLegally marketed deviceCardioDay Version 1.9.5(K051471)New/ Modified DeviceCardioDay Version 2.0
The following comparison between the legally mar-keted device and the NEW DEVICE is based on theirfunctionality only. The commands to generate agiven printout as well as its appearance do vary.
Full Disclosure 2 Channels, 1 h/PageYesYes
Full Disclosure 2 Channels, 15 min./PageYesYes
Full Disclosure 2 Channels, 30 min./PageYesYes
Marked Events: 8 Events/PageYesYes

0505S1-Sec16-0001-RevB-CardioDay-510k_Summary.doc
CONFIDENTIAL AND PROPRIETARY

7-2-1 . ++

{5}------------------------------------------------

Special 510(k) Notificationgetemed
CardioDay®Project ID: 0505S1
Executive - SummarySection 16-0001-Rev B
Printout OptionsLegally marketed deviceCardioDay® Version 1.9.5(K051471)New / Modified DeviceCardioDay® Version 2.0
Marked Events: 32 Events/PageYesYes
Marked Events: Analysis Channel 25 mm/sYesYes
Marked Events: Analysis Channel 2.5 min + 25mm/sYesYes
Selected Channels 25 mm/sYesYes
Selected Channels 1 min. + 25 mm/sYesYes
Selected Channels 2.5 min. + 25 mm/sYesYes
Selected Channels 10 min. + 25 mm/sYesYes
Event TableYesYes
Event HistogramYesYes
Heart Rate and ST DiagramsYesYes
HR diagram + Min/Max per MinuteYesYes
RR IntervalsYesYes
RR DelayYesYes
RR HistogramsYesYes
RR Interval SpectraYesYes
Pacemaker Event HistogramYesYes
Pacemaker Function AnalysisYesYes
ReportYesYes
Print to File (PDF)YesYes
Save as Default OptionYesYes
Editing & Reviewing OptionsLegally marketed deviceCardioDay Version 1.9.5(K051471)New / Modified DeviceCardioDay Version 2.0
The following comparison between the legally mar-keted device and the NEW DEVICE is based on theirfunctions only. The label and appearance of thoseoptions may vary.
Scroll through all Beats in a Morphology BinYesYes
Edit all Beat Labels in a Morphology BinYesYes
Scroll through ECG and Edit Single Beat LabelsYesYes
Scroll through Events of the Same TypeYesYes
Edit Event MarkerYesYes
View Patient Event MarkersYesYes
Jump from any Statistics Diagram to thecorresponding ECGYesYes
Jump from ECG Overview to the corresponding ECGYesYes
Select Time Interval for Time Domain RR ParametersYesYes
Edit ReportYesYes

『 、 : 人

{6}------------------------------------------------

Special 510(k) Notification

CardioDay®Project ID: 0505S1
Executive - SummarySection 16-0001-Rev B
MiscellaneousLegally marketed deviceCardioDay Version 1.9.5(K051471)New / Modified DeviceCardioDay Version 2.0
RZ153+ Digital Recorder Supported (K022540)YesYes
CardioMem® CM 3000 (SMA) SupportedYesYes
CardioMem® CM 3000-12 Supported (K051686)YesYes
CardioMem® CM 3000-12BT SupportedNoYesBluetooth functionalityonly with MicrosoftWindows XP (SP2)
CD Installation MediumYesYes

Standards Comparison

StandardLegally marketed deviceCardioDay Version 1.9.5(K051471)New / Modified DeviceCardioDay Version 2.0
21 CFR 820 (FDA cGMP Good ManufacturingPractice)YesYes
ISO 9001:2000 / ISO 13485:2003 QualityManagement SystemsYesYes
IEC 60601-1-4 + A1 Programmable ElectricalMedical SystemsYesYes
ANSI/AAMI EC38 Ambulatory ElectrocardiographsYesYes
IEC 60601-2-47 Particular Requirements for theSafety, including Essential Performance, ofAmbulatory Electrocardiographic SystemsYesYes
ISO 14971 +A1 Application of the RiskManagement to Medical DevicesYesYes
EN 980 Graphic Symbols for the Marking ofMedical DevicesYesYes
EN 1041 Supply of Information by the Manufacturerof a Medical DeviceYesYes
ISO 15223 + AMD1 + AMD2 Symbols to be Usedwith Medical DevicesYesYes

Intended use:

CardioDay® is a software package that allows a trained physician or health care professional knowledgeable in Holter ECG interpretation, after having performed a long-term continuous electrocardiographic (ECG) recording using a digital flash memory Holter recorder, to download and analyze the data from the recorder, review it and produce printed reports.

This device is available only upon the order of a physician or other licensed medical professional and not intended for any ambulatory or home applications.

United States federal law restricts CardioDay® to sale by or on the order of a physician.

0505S1-Sec16-0001-RevB-CardioDay-510k_Summary.doc CONFIDENTIAL AND PROPRIETARY

{7}------------------------------------------------

Special 510(k) Notificationgetemed
CardioDay®Project ID: 0505S1
Executive - SummarySection 16-0001-Rev B

Non-Clinical Testing:

Verification and validation test plans were completed in accordance with getemed AG procedures and GMP guidelines. A Hazard Analysis was completed and hazards were resolved as appropriate.

The CardioDay® software complies to the following standards:

  • IEC 60601-1-4,
  • IEC 60601-2-47,
  • IEC 60601-2-51 (Part 50.101.2),
  • ANSI/AAMI EC 38,
  • ISO 14971.
  • EN 980,
  • ISO 15223,
  • EN 1041

Also the following FDA-Guidelines were met:

  • "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices",
  • "General Principles of Software Validation".

All system specifications were met and testing performed to demonstrate substantial equivalence.

Clinical Testing:

Clinical testing was not required to demonstrate substantial equivalence of safety and effectiveness.

Conclusion:

The CardioDay® evaluation software is substantially equivalent to the predicate device listed in this Summary and the device, as changed, does not raise any new issues of safety and effectiveness.

    • 16

{8}------------------------------------------------

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

FEB 2 3 2007

Getemed Medizin c/o Mr. Bert Schadow Regulatory Affairs Manager 14514 Teltow Germany

Re: K070280

Trade Name: CardioDay Regulation Number: 21 CFR 870.1425 Regulation Name: Computer, Diagnostic, Programmable Regulatory Class: Class II Product Code: DQK Dated: January 3, 2007 Received: January 29, 2007

Dear Mr. Schadow:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

{9}------------------------------------------------

Page 2 - Mr. Schadow

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Brimmerfor

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{10}------------------------------------------------

K070280
Exhibit 1

Image /page/10/Picture/1 description: The image shows the logo for Getemed. The logo consists of a heart shape inside a circle, followed by the word "getemed" in bold, sans-serif font. The heart and the text are both black, and the background is white.

Medizin- und Informationstechnik AG

Indications for Use

510(k) Number (if known):

CardioDay® Device Name:

Indications For Use:

CardioDay® is a Holter software which is indicated for patients who may benefit from a long-term continuous electrocardiographic (ECG) recording, including, but not limited to, those with complaints of palpitations, syncope, chest pain, shortness of breath, or those that need to be monitored to judge their current cardiac functionality such as patients who have recently received pacemakers.

న Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

K.Bermmmo

Page 1 of

Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number K070280

§ 870.1425 Programmable diagnostic computer.

(a)
Identification. A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.(b)
Classification. Class II (performance standards).